首页> 外文期刊>Molecular and Cellular Biochemistry: An International Journal for Chemical Biology >Evaluation of the anti-atherogenic potential of chrysin in Wistar rats
【24h】

Evaluation of the anti-atherogenic potential of chrysin in Wistar rats

机译:Wistar大鼠蛹的抗动脉膜发生评价

获取原文
获取原文并翻译 | 示例
       

摘要

Hypercholesterolemia is one of the major risk factors that precipitate coronary heart disease and atherosclerosis. Oxidative stress is believed to contribute to the pathogenesis of hypercholesterolemic atherosclerosis; hence, various antioxidant compounds are being evaluated for potential anti-atherogenic effects. In the present study, the putative anti-atherogenic and antioxidant efficacy of a flavonoid, chrysin, was evaluated in an experimental model of atherosclerosis. In male, albino Wistar rats fed an atherogenic diet for 45 days and treated with saline, significantly higher mean levels of serum lipid profile parameters (total cholesterol, triglycerides, low-density, and very low-density lipoprotein cholesterol), lower mean levels of high-density lipoprotein cholesterol and higher mean serum levels of hepatic marker enzymes (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and lactate dehydrogenase) were observed when compared with the levels in rats fed a control diet. In addition, significantly lower mean hepatic levels of lipoprotein lipase, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, antioxidant enzymes (catalase, superoxide dismutase, and glutathione peroxidase) and non-enzymatic antioxidants (reduced glutathione, and vitamins C and E), and a significantly higher mean level of hepatic malondialdehyde (MDA) were noted in comparison to the values in control rats. In atherogenic diet-fed rats that received chrysin orally (200 mg/kg b.wt) for 15 days, starting 30 days after the start of the atherogenic diet, significantly lower mean serum levels of lipid profile parameters (except for HDL-cholesterol which was elevated), hepatic marker enzymes, and significantly higher mean hepatic levels of LPL, HMG-CoA reductase, enzymatic, and non-enzymatic antioxidants and significantly lower mean levels of hepatic MDA were noted, compared to the values in atherogenic diet-fed, saline-treated rats. Histopathological studies appeared to suggest the protective effect of chrysin on the hepatic tissue and aorta of atherosclerotic rats. These results suggest that chrysin has anti-atherogenic potential in an experimental setting.
机译:高胆固醇血症是促使冠心病和动脉粥样硬化的主要危险因素之一。据信氧化应激有助于高胆固醇血症动脉粥样硬化的发病机制;因此,正在评估各种抗氧化化合物以进行潜在的抗动脉粥生成作用。在本研究中,在动脉粥样硬化的实验模型中评估了黄酮类化合物的推定的抗动脉抑制和抗氧化效果。在雄性中,白化Wistar大鼠喂养致动脉粥样硬化饮食45天并用盐水处理,血清脂质曲线参数的平均水平显着更高(总胆固醇,甘油三酯,低密度和非常低密度的脂蛋白胆固醇),较低平均水平与喂养对照饮食的大鼠水平相比,观察到高密度脂蛋白胆固醇和肝脏标记酶的肝脏标记酶(天冬氨酸氨基转移酶,丙氨酸氨基转移酶,丙氨酸氨基转移酶,碱性磷酸酶和乳酸脱氢酶)。此外,显着低于脂蛋白脂肪酶的平均肝水平,3-羟基-3-甲基戊族 - 辅酶A(HMG-COA)还原酶,抗氧化酶(过氧化氢酶,超氧化物歧化酶和谷胱甘肽过氧化物酶)和非酶促抗氧化剂(减少谷胱甘肽,与维生素C和e)和维生素C和e)和肝丙二醛(MDA)的显着提高平均水平与对照大鼠的值相比,并进行了相比。在肌内饮食喂养的大鼠中,在口服(200mg / kg b.wt)的蛹(200mg / kg b.wt)开始15天,在动脉发生饮食开始30天开始,显着降低平均血清素曲线参数(HDL-胆固醇除外)升高),肝脏标记酶,LPL,HMG-COA还原酶,酶和非酶促抗氧化剂的显着提高,肝脏MDA的显着较低,盐水处理的大鼠。组织病理学研究似乎表明Chrysin对动脉粥样硬化大鼠肝组织和主动脉的保护作用。这些结果表明Chrysin在实验环境中具有抗动脉发生潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号